Skip to main content
. 2014 May 15;2014:854521. doi: 10.1155/2014/854521

Figure 2.

Figure 2

Interactions between globotriaosylceramide (GL-3), uPAR, plasminogen/plasmin, and integrin αvβ3 and the development of proteinuria in Fabry disease, counteracted by amiloride.